CLINICAL_TRIALS
research
· 2017-09-01
Clinical Trial Update: Age Gene/Environment Susceptibility Reykjavik Study
Summary
The Icelandic Heart Association reports the completed status of the Age Gene/Environment Susceptibility Reykjavik Study assessing risks related to neoplasms.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Icelandic Heart Association | Conditions: Neoplasms | Status: COMPLETED